Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
Learn More
Abnova™ CXCL13 (Human) ELISA Kit
In-Vitro Enzyme-Linked Immunosorbent assay for the quantitative measurement of Human CXCL13
Supplier: Abnova™ KA1697
Includes:
- BLC Microplate (Item A): coated with anti-human BLC, 96-wells (12 strips x 8 wells)
- Wash Buffer Concentrate (20x) (Item B): 20x concentrated solution, 25mL
- Standard recombinant human BLC (Item C), 2 vials
- Assay Diluent A (Item D): 0.09% sodium azide as preservative, For Standard/Sample (serum/plasma) diluent, 30mL
- Assay Diluent B (Item E): 5x concentrated buffer, For Standard/Sample (cell culture medium/urine) diluent, 15mL
- Detection Antibody BLC (Item F): Biotinylated anti-human BLC (each vial is enough to assay half microplate), 2 vials
- HRP-Streptavidin Concentrate (Item G): 200x concentrated, HRP-conjugated Streptavidin, 200μL
- TMB One-Step Substrate Reagent (Item H): 3, 3', 5, 5'-tetramethylbenzidine (TMB) in buffered solution, 12mL
- Stop Solution (Item I): 0.2M sulfuric acid, 8mL
Specifications
Biotin | |
CXCL13 (Human) ELISA Kit is an in vitro enzyme-linked immunosorbent assay for the quantitative measurement of human CXCL13. | |
Colorimetric | |
96 Assays | |
100 μL | |
Quantification |
Human | |
1.5pg/mL | |
96-well Antibody coated microwell, 25mL Wash Buffer 20X, 2 vials standard, 30mL assay diluent A, 15mL assay diluent B, 2 vials detection Antibody MSP, 8μL HRP Streptavidian concentrate, 12mL TMB One-Step Substrate reagent, 8mL stop solut | |
Cell Culture Supernatant, Plasma, Serum, Urine | |
Store the kit at -20°C. For best results, please store the components as described in the protocol. Avoid repeated freezing and thawing. | |
CXCL13 (Human) ELISA Kit |
Provide Content Correction
We continue to work to improve your shopping experience and your feedback regarding this content is very important to us. Please use the form below to provide feedback related to the content on this product.
Product Title
Spot an opportunity for improvement?
Provide Content Correction